4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-25-017592
Chief Executive Officer sold 141,122 shares at an average $10.87 ($1,533,337)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2025-04-09 | Sale | −35,305 | $9.93 | $350,579 | 4,027,072 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2025-04-09 | Sale | −3,400 | $10.75 | $36,550 | 4,023,672 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2025-04-09 | Sale | −1,617 | $11.76 | $19,016 | 4,022,055 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2025-04-10 | Sale | −50,000 | $10.87 | $543,500 | 3,972,055 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2025-04-11 | Sale | −50,800 | $11.49 | $583,692 | 3,921,255 | D |
| Open-market sales · 141,122 sh · avg $10.87 · $1,533,337 | |||||||
Loading xslF345X05/wk-form4_1744410000.xml…